Cell Expansion Market is Projected to Reach US$ 42,837.11 Mn in 2027 With Key Companies Like BD, Merck KGaA, Thermo Fisher Scientific, Inc., Terumo Corporation, GE Company

According to a new market research study of ‘‘Cell Expansion Market to 2027 – Global Analysis and Forecasts by Product, Cell Type, Application, End User’ the global cell expansion market is projected to reach US$ 42,837.11 Mn in 2027 from US$ 11,929.43 Mn in 2018. The market is projected to grow with a CAGR of 15.6% from 2019-2027. The report provides trends predominating in the global Cell Expansion market and the factors driving the market and also the factors that act as hindrances.

Get Sample PDF Of Report@ https://www.theinsightpartners.com/sample/TIPRE00006576/?op-10186

The significant factors fuelling the market growth are increasing adoption of regenerative medicines and rising prevalence of cancer. However, the risk contamination during cell expansion is expected to hamper the market during the forecast period.

The cell expansion market majorly consists of players such as BD, Merck KGaA, Thermo Fisher Scientific, Inc., Terumo Corporation, General Electric Company, Corning Incorporated, Miltenyi Biotec, Danaher, Lonza and STEMCELL TECHNOLOGIES, INC. among others. Several companies are concentrating on organic strategies, such as product launch and product approvals. For instance, in October 2019, Thermo Fisher Scientific, under its brand Gibco, introduced Gibco BenchStable Media.

Regenerative medicine has the potential to replace or heal tissues as well as organs damaged by age, disease, or trauma, as well as to normalize congenital defects. Over the last quarter of a century, there has been an emergence of a tissue engineering industry, one that has now evolved into the broader area of regenerative medicine.
Regenerative medicine is defined as a rapidly growing interdisciplinary field that involves engineering sciences to develop clinical therapies intended for maintenance, repair, replacement and enhancement of biological function.

Cell expansion is a crucial and invariable part of regenerative medicine. On the bases of study and investigation, desired regeneration techniques are used to develop the tissue which involves cell expansion procedures. It helps to understand how to treat injuries and diseases from broken bones to neurodegenerative diseases. Thus, the rise in the adoption of regenerative medicines is expected to foster the demand for cell expansion procedures thereby driving the market growth. Therefore, owing to the factors mentioned above, the market is likely to propel during the forecast period.

In 2018, the human cells segment accounted for the largest market share in the global cell expansion market by cell type. Factors such as rising investments by public and private organizations for research on human cells such as stem cells, growing application areas of human stem cells, and the growing awareness regarding stem cell therapies.

The report segments global cell expansion market as follows:

• Global Cell Expansion Market – By Product
o Consumables
o Instruments

• Global Cell Expansion Market – By Cell Type
o Human Cells
o Animal Cells

• Global Cell Expansion Market – By Application
o Regenerative Medicine and Stem Cell Research
o Cancer and Cell-based Research
o Other Applications

• Global Cell Expansion Market – By End User
o Biopharmaceutical and Biotechnology Companies
o Research Institutes
o Cell Banks
o Other End Users

• Global Cell Expansion Market – By Geography
• North America
• Europe
• Asia Pacific (APAC)
• Middle East & Africa (MEA)
• South & Central America (SCAM)

The Cell Expansion market majorly consists of players such as BD, Merck KGaA, Thermo Fisher Scientific, Inc., Terumo Corporation, General Electric Company, Corning Incorporated, Miltenyi Biotec, Danaher, Lonza and STEMCELL TECHNOLOGIES, INC. among others. Several companies are concentrating on organic strategies, such as product launch and product approvals. For instance, in October 2019, Merck acquired FloDesign Sonics, a US-based company. FloDesign Sonics is a developer of a unique acoustic cell processing platform that is applicable for the industrial application of cell and gene therapy manufacturing. Thermo Fisher Scientific, under its brand Gibco, introduced Gibco BenchStable Media.

Buy Full Report@ https://www.theinsightpartners.com/buy/TIPRE00006576/?op-10186

Contact us:

The Insight partners,

Phone: +1-646-491-9876

Email: sales@theinsightpartners.com

About The Insight Partners

The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Healthcare, Media, and Telecommunication.

Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis.

Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, products, applications, end users etc., which helps our clients to gain a deeper analytical understanding of various research topics.

This release was published on openPR.